Jeffrey O’Callaghan

Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment

Chris Greene, Ruairi Connolly, Declan Brennan et al. · Nature Neuroscience · 2024 · 371 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma

Jeffrey O’Callaghan, Darragh E. Crosbie, Paul Cassidy et al. · Human Molecular Genetics · 2017 · 86 citations · Full text

Medicine, Ophthalmology, Ocular Disease +16

Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma

Rory Murphy, Mustapha Irnaten, Jeffrey O’Callaghan et al. · Investigative Ophthalmology & Visual Science · 2022 · 34 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Fibrotic Changes to Schlemm’s Canal Endothelial Cells in Glaucoma

Ruth A. Kelly, Kristin Perkumas, Matthew Campbell et al. · International Journal of Molecular Sciences · 2021 · 33 citations · Full text

Medicine, Cell Biology, Ophthalmology +14

Matrix metalloproteinase-3 (MMP-3)–mediated gene therapy for glaucoma

Jeffrey O’Callaghan, Conor P. Delaney, Merissa E. O’Connor et al. · Science Advances · 2023 · 31 citations · Full text

Medicine, Molecular Medicine, Ophthalmology +15